Company Overview - Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing next-generation antibody complement therapeutics for severe autoimmune diseases [3] - The company is based in New York City and Waltham, Massachusetts, and is led by an experienced team of biotech and pharma executives [3] Upcoming Events - The company will participate in the Jefferies Global Healthcare Conference, with CEO Marino Garcia scheduled for a fireside chat on June 5, 2025, at 9:55 a.m. EDT [1] - One-on-one meetings with investors will also be hosted by the CEO during the conference [1] Investor Relations - A live webcast of the company's presentation will be available under the "News and Events" section on the Dianthus Therapeutics website [2]